J Bone Metab.  2018 Feb;25(1):1-7. 10.11005/jbm.2018.25.1.1.

Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea

• Yoo JI
• Ha YC

• KMID: 2406233
• DOI: http://doi.org/10.11005/jbm.2018.25.1.1

Abstract

Sarcopenia was listed in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) as M62.84, on October 1, 2016. Sarcopenia is primarily associated with metabolic diseases, such as diabetes, obesity, and cachexia, as well as chronic renal failure, congestive heart failure, and chronic obstructive pulmonary disease. Sarcopenia is also significantly associated with osteoporosis in elderly populations and the combined disease is defined as osteosarcopenia. Several studies have confirmed that sarcopenia and osteoporosis (osteosarcopenia) share common risk factors and biological pathways. Osteosarcopenia is associated with significant physical disability, representing a significant threat to the loss of independence in later life. However, the pathophysiology and diagnosis of osteosarcopenia are not fully defined. Additionally, pharmacologic and hormonal treatments for sarcopenia are undergoing clinical trials. This review summarizes the epidemiology, pathophysiology, diagnosis, and treatment of osteosarcopenia, and includes Korean data.

Keyword

Diagnosis; Epidemiology; Osteoporosis; Sarcopenia; Therapeutics

MeSH Terms

Aged
Cachexia
Diagnosis*
Epidemiology*
Heart Failure
Humans
International Classification of Diseases
Kidney Failure, Chronic
Korea*
Metabolic Diseases
Obesity
Osteoporosis
Pulmonary Disease, Chronic Obstructive
Risk Factors
Sarcopenia

Reference

1. Lim JW. The changing trends in live birth statistics in Korea, 1970 to 2010. Korean J Pediatr. 2011; 54:429–435.

2. Ha YC, Kim TY, Lee A, et al. Current trends and future projections of hip fracture in South Korea using nationwide claims data. Osteoporos Int. 2016; 27:2603–2609.

3. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995; 50 Spec No:11–16.

4. Zhai G, Hart DJ, Valdes AM, et al. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int. 2008; 19:1211–1217.

5. Choi YJ, Oh HJ, Kim DJ, et al. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008–2009. J Bone Miner Res. 2012; 27:1879–1886.

6. Kwon YJ, Park KS, Choi BH, et al. Prevalence of osteoporosis and effectiveness of screening test using ultrasound bone densitometry and education in a community-dwelling population. J Korean Med Sci. 2017; 32:352–356.

7. Park C, Ha YC, Jang S, et al. The incidence and residual life-time risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.

8. Short KR, Vittone JL, Bigelow ML, et al. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab. 2004; 286:E92–E101.

9. von Haehling S, Morley JE, Anker SD. From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle. 2012; 3:213–217.

10. Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016; 31:643–650.

11. Kwon HJ, Ha YC, Park HM. Prevalence of sarcopenia in the Korean woman based on the Korean national health and nutritional examination surveys. J Bone Metab. 2016; 23:23–26.

12. Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int. 2013; 13:413–420.

13. Di Monaco M, Castiglioni C, Vallero F, et al. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr. 2012; 55:e48–e52.

14. Yoo JI, Ha YC, Kwon HB, et al. High prevalence of sarcopenia in Korean patients after hip fracture: a case-control study. J Korean Med Sci. 2016; 31:1479–1484.

15. Yoo JI, Kim H, Ha YC, et al. Osteosarcopenia in patients with hip fracture Is related with high mortality. J Korean Med Sci. 2018; 33:e27.

16. Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015; 16:290–295.

17. Wang YJ, Wang Y, Zhan JK, et al. Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol. 2015; 2015:482940.

18. Drey M, Sieber CC, Bertsch T, et al. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res. 2016; 28:895–899.

19. Goodman CA, Hornberger TA, Robling AG. Bone and skeletal muscle: key players in mechanotransduction and potential overlapping mechanisms. Bone. 2015; 80:24–36.

20. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol. 2000; 16:191–220.

21. Garatachea N, Lucía A. Genes and the ageing muscle: a review on genetic association studies. Age (Dordr). 2013; 35:207–233.

22. Tan LJ, Liu SL, Lei SF, et al. Molecular genetic studies of gene identification for sarcopenia. Hum Genet. 2012; 131:1–31.

23. Cho J, Lee I, Kang H. ACTN3 gene and susceptibility to sarcopenia and osteoporotic status in older Korean adults. Biomed Res Int. 2017; 2017:4239648.

24. González-Mercado A, Sánchez-López JY, Regla-Nava JA, et al. Association analysis of vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Mexican-Mestizo women. Genet Mol Res. 2013; 12:2755–2763.

25. Karasik D, Kiel DP. Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res. 2008; 23:788–802.

26. Reed T, Fabsitz RR, Selby JV, et al. Genetic influences and grip strength norms in the NHLBI twin study males aged 59–69. Ann Hum Biol. 1991; 18:425–432.

27. Arden NK, Spector TD. Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res. 1997; 12:2076–2081.

28. Kang SY, Lim GE, Kim YK, et al. Association between sarcopenic obesity and metabolic syndrome in postmenopausal women: a cross-sectional study based on the Korean national health and nutritional examination surveys from 2008 to 2011. J Bone Metab. 2017; 24:9–14.

29. Kaji H. Interaction between muscle and bone. J Bone Metab. 2014; 21:29–40.

30. Kim HY, Jang EJ, Park B, et al. Development of a Korean fracture risk score (KFRS) for predicting osteoporotic fracture risk: Analysis of data from the Korean national health insurance service. PLoS One. 2016; 11:e0158918.

31. Lee WJ, Liu LK, Peng LN, et al. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc. 2013; 14:528.e1–528.e7.

32. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014; 15:95–101.

33. Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int. 2017; 28:189–199.

34. Buehring B, Krueger D, Binkley N. Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle. 2013; 4:47–54.

35. Bruyère O, Cavalier E, Reginster JY. Vitamin D and osteosarcopenia: an update from epidemiological studies. Curr Opin Clin Nutr Metab Care. 2017; 20:498–503.

36. Sakuma K, Yamaguchi A. Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia. Pflugers Arch. 2018; 470:449–460.

37. Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013; 24:23–57.

38. Deutz NE, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014; 33:929–936.

39. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013; 14:542–559.

40. Kim CO, Lee KR. Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study. J Gerontol A Biol Sci Med Sci. 2013; 68:309–316.

41. Peterson MD, Rhea MR, Sen A, et al. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010; 9:226–237.

42. Law TD, Clark LA, Clark BC. Resistance exercise to prevent and manage sarcopenia and dynapenia. Annu Rev Gerontol Geriatr. 2016; 36:205–228.

43. Kim KI, Jung HK, Kim CO, et al. Evidence-based guidelines for fall prevention in Korea. Korean J Intern Med. 2017; 32:199–210.